Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 20th International Myeloma Society (IMS) Annual Meeting was held in Athens, Greece, from 27-30 September, 2023. This meeting focused on the latest basic, preclinical, and clinical advances in the field of multiple myeloma.    
View all videos

IMS 2023

The 20th International Myeloma Society Annual Meeting
27–30 September 2023 | Athens, Greece

IMS 2023

The 20th International Myeloma Society Annual Meeting
27–30 September 2023 | Athens, Greece
The 20th International Myeloma Society (IMS) Annual Meeting was held in Athens, Greece, from 27-30 September, 2023. This meeting focused on the latest basic, preclinical, and clinical advances in the field of multiple myeloma.    
View all videos

Latest videos

View all videos
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
2:25
Biomarkers of progression and risk stratification in asymptomatic Waldenström’s macroglobulinemia
Mark Bustoros • 27 Sep 2023
1:11
Advances that have been made in the molecular characterization of multiple myeloma
Mark Bustoros • 27 Sep 2023
1:50
Molecular characteristics of extramedullary myeloma
Mark Bustoros • 27 Sep 2023

Immuno-oncology

View all
2:15
IMAGE subgroup analysis: real-world experience of Isa-Pd in patients with R/R multiple myeloma
Xavier Leleu • 29 Sep 2023
1:30
First-in-human study of autologous memory-like NK cells in patients with MRD+ multiple myeloma
Giada Bianchi • 29 Sep 2023

Amyloidosis

View all
1:53
Novel laboratory-based therapeutic approach in AL amyloidosis: investigating FLC secretion
Giada Bianchi • 29 Sep 2023
2:27
Factors affecting the accuracy of amyloidosis identification and referral to a specialty center
Vaishali Sanchorawala • 29 Sep 2023
The content of VJHemOnc is intended for healthcare professionals